Bracco cleared two AI tools for brain aneurysms on head CT angiography, the company and Avicenna.AI said on November 13. CINA-Aneurysm, sold as UPTUNITY Aneurysm Detection, cleared under K262062. CINA-Aneurysm+, sold as UPTUNITY Aneurysm Management, cleared under K262147.
The detection tool is a concurrent reading aid for suspected saccular aneurysms larger than 3 mm, flagging presence, location and size for a trained reader. The second tool handles known aneurysms, producing quantitative measurements and comparing them across exams over time. Neither replaces a full patient evaluation or physician review.
Avicenna.AI built the CINA line and will lead promotion and commercial distribution. The French company, founded in 2018 and based in La Ciotat, already sells FDA-cleared CT triage tools for intracranial hemorrhage, large vessel occlusion, pulmonary embolism and spine fractures. Bracco, founded in 1927, holds the clearances. Selling a reading aid through a contrast agent business puts the software in front of departments that are already buying from the same vendor, which is a shorter path than a standalone AI sale.